Accredo Specialty Pharmacy | Accredo Patient Support

We are committed to making CARBAGLU affordable and accessible.

zero co-pay

Recordati Rare Diseases, the distributor of CARBAGLU® (carglumic acid) tablets for oral suspension 200mg, is offering a $0 copay for qualified patients with commercial insurance. CARBAGLU has a proven track record of quality, safety, and efficacy, as well as personalized patient support programs for people taking CARBAGLU. Although we do not replace the advice of your doctor, we can help you with your questions. We have you covered!

1-888-454-8860 (toll-free)

Recordati Rare Diseases Patient Support Program

Contact the Recordati Rare Diseases Patient Support Program for help with:

  • Co-Pay Support Program

    Get help with Insurance co-pay and co-insurance costs. Find out if you qualify for a $0 co-pay for CARBAGLU.

  • Insurance Verification

    Get help with confirming that your insurance company will cover CARBAGLU, and get help in understanding your insurance plan benefits.

  • Prior Authorization Support

    Get help working with your doctor’s office and insurance company if additional approvals are needed.

  • General Inquiries

    Get answers to any questions related to accessing CARBAGLU.

  • Alternate Funding Referrals

    Get help in researching alternative forms of medication coverage, or get referrals to other possible sources of funding.

  • Patient Assistance Program

    Get assistance with accessing medications if you don’t have insurance or are underinsured.*

    *Eligibility requirements may apply.

Where can I get more support?

For more information about NAGS deficiency, PA, and MMA, check out these resources:

  • Organic Acidemia Association - logo

    The mission of the Organic Acidemia Association is to find improved treatments and a cure for propionic acidemia (PA) and methylmalonic acidemia (MMA) by funding research and providing information and support to families and medical professionals. Services and programs for families include educational materials, family matching to enable families to talk to each other, and an email group.

  • Propionic Acidemia Foundation - logo

    The mission of the Propionic Acidemia Foundation is to find improved treatments and a cure for propionic acidemia (PA) by funding research and providing information and support to families and medical professionals. Services and programs for families include educational materials, family matching to enable families to talk to each other, and an email group.

  • National Urea Cycle Disorders Foundation (NUCDF) - logo

    The National Urea Cycle Disorders Foundation (NUCDF) is dedicated to the identification, treatment, and cure of urea cycle disorders. NUCDF provides information and education for families and doctors. NUCDF offers two support programs for families: a mentor program, which matches newly diagnosed families with a mentor from the UCD community; and a networking program, which enables UCD patients and families to communicate with each other.

  • Genetic and Rare Diseases Information Center (GARD) - logo

    Genetic and Rare Diseases Information Center (GARD) of the National Institutes of Health provides information for individuals with genetic and rare diseases, their families, and others.

  • National Organization for Rare Disorders (NORD) - logo

    The National Organization for Rare Disorders (NORD) is dedicated to helping people with rare diseases. NORD provides information and resources for families, as well as ways to connect with others and get involved in the rare diseases community.

  • Rare Diseases Clinical Research Network | National Insititute of Health - logo

    The Urea Cycle Disorders Consortium, part of the Rare Diseases Clinical Research Network founded by the National Institutes of Health, is a team of doctors, nurses, and researchers working together to improve the lives of people with urea cycle disorders through research and education. The purpose of the consortium is to provide ways for patients to join with doctors and researchers through participation in research studies.

X
X
X